ODTX (Odyssey Therapeutics, Inc. Common Stock) Stock Analysis
Odyssey Therapeutics, Inc. Common Stock (ODTX) is a publicly traded the market company. As of May 21, 2026, ODTX trades at $16.97 with a market cap of $820.36M and a P/E ratio of 0.00. ODTX moved +0.35% today. Year to date, ODTX is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $15.35 to $20.30. Rallies surfaces ODTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What is the latest ODTX stock research?
Odyssey Therapeutics, Inc. Common Stock (ODTX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ODTX moved +0.35% today.
TPG GP A, LLC bought 1.39M (~$25.00M) on May 11, 2026.
SR ONE CAPITAL MANAGEMENT, LLC sold 1.06K (~$19.17K) on May 11, 2026.
SR ONE CAPITAL MANAGEMENT, LLC bought 222.22K (~$4.00M) on May 11, 2026.
ODTX Analyst Consensus
ODTX analyst coverage data. Average price target: $0.00.
Common questions about ODTX
What can I research for ODTX on Rallies?
Odyssey Therapeutics, Inc. Common Stock (ODTX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ODTX moved +0.35% today.
Does Rallies show live market data for ODTX?
Rallies combines live market context with ticker research for ODTX, including charts, news, financials, analyst data, institutional holdings, politician trades, insider activity, and AI research where available.
